Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro
about
MicroRNA-145 targets YES and STAT1 in colon cancer cellsmiR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancerFilopodia and adhesion in cancer cell motilityTumor and stromal-based contributions to head and neck squamous cell carcinoma invasionFascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancerExpression of fascin-1, an actin-bundling protein, in migrating hepatoblasts during rat liver developmentDual actin-bundling and protein kinase C-binding activities of fascin regulate carcinoma cell migration downstream of Rac and contribute to metastasisFascin1 is dispensable for mouse development but is favorable for neonatal survivalFascin 1 is transiently expressed in mouse melanoblasts during development and promotes migration and proliferation.Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma.Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancerPrognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas.Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade.Neurotrophin 3/TrkC-regulated proteins in the human medulloblastoma cell line DAOY.Fascin-1 promoter activity is regulated by CREB and the aryl hydrocarbon receptor in human carcinoma cells.Evaluation of fascin-1 expression as a marker of invasion in urothelial carcinomasInvolvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells.Reduced EBP50 expression levels are correlated with unfavorable clinicopathological features of extrahepatic bile duct carcinoma and promote the proliferation and migration of QBC939 cells.Fascin expression in colorectal carcinomas.The actin-bundling protein fascin is overexpressed in inflammatory bowel disease and may be important in tissue repairAssociation of Fascin and matrix metalloproteinase-9 expression with poor prognostic parameters in breast carcinoma of Egyptian women.Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma.Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion.E-cadherin and the cytoskeletal network in colorectal cancer development and metastasis.Mechanics and dynamics of actin-driven thin membrane protrusions.A cell-based fascin bioassay identifies compounds with potential anti-metastasis or cognition-enhancing functions.Fascin-1, ezrin and paxillin contribute to the malignant progression and are predictors of clinical prognosis in laryngeal squamous cell carcinoma.Overexpression of FOXM1 is associated with metastases of nasopharyngeal carcinomaGlobal gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypesDifferential protein expression profiles in estrogen receptor-positive and -negative breast cancer tissues using label-free quantitative proteomics.Stable differences in intrinsic mitochondrial membrane potential of tumor cell subpopulations reflect phenotypic heterogeneity.MiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinomaHigher molecular weight polyethylene glycol increases cell proliferation while improving barrier function in an in vitro colon cancer model.Fascin promotes the motility and invasiveness of pancreatic cancer cells.The role of actin bundling proteins in the assembly of filopodia in epithelial cellsFascin and CK4 as biomarkers for esophageal squamous cell carcinoma.Immunohistochemical analysis of oral dysplasia: diagnostic assessment by fascin and podoplanin expressionFascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma.MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1.The role of fascin in the migration and invasiveness of malignant glioma cells.
P2860
Q21142669-C18685F4-55D1-41F7-B09D-EB946F2CB1BCQ24632886-8FD276D1-2754-4B0F-A4F1-0112C42318DBQ26823315-5B73AB8A-4557-4FFD-816E-950BDCE82D80Q26825164-EF93D622-CE3A-4B31-858D-0995CC11A36BQ28237071-CA825C6C-8C45-49A1-A896-EE5FD5AC2B35Q28574977-D95D7252-1C99-4F47-BC6D-B1241CD1E650Q30480311-6FD107C9-BD2C-415E-A9E4-75FC96AAF719Q30490009-602DC1CF-6181-45B8-B8D6-592E7A156EF1Q30570724-D82B40B0-F247-485C-A816-2D73E0E34F8AQ33214805-38186E97-BABC-49D8-8C99-074C59B0CDCAQ33252508-DEB7E68A-3BE4-4064-8327-597ADB9439F5Q33259830-C93A020A-4FD6-483E-8E36-77248DD9B4E8Q33280569-FE4F0193-B3B7-488E-88D9-8FF460161808Q33401329-FCB2D542-EEA5-4E7F-A3A8-044A9F8B83FDQ33425930-7CCB1002-BC83-4961-9E76-3BE235AFA8A3Q33595329-2CEBFDF3-A421-4857-9BF2-28C13DC0F675Q33597230-DB5CF90D-FB23-4E73-9A73-DD8F0084BB55Q33597837-2BF018B6-6EAE-4477-9B9B-631C73CB30C6Q33684686-1CF030F0-FF1D-4A23-AC99-FE390369FE72Q33827631-4A0D3217-5A22-454B-BAAF-182F103184E4Q33904564-0EE06520-1C36-4BD9-AEA6-3E730C1C40F6Q34134515-9F4518C9-9BCA-4CCB-9577-D742408AB369Q34146970-3AC68148-77CA-4E31-A26B-5922789B32F6Q34241196-D248B498-6996-46A4-812B-A2498CDBE091Q34352886-048B6F9E-86B9-4739-97D1-1B41E455D3F9Q34392217-CA8AB32C-9247-4E3D-87D3-C6F30A7CBFA9Q34500644-58CBC0DC-0F49-493B-86FC-451FE38A3590Q34589178-EC40A88F-75BB-4434-8A09-CCE27D5F360BQ34917292-8720000E-F3F4-4ADE-8280-6DCC09C484C4Q34972287-7902A173-AA18-42BF-A31E-9981FBEF6AF6Q35094399-963A1570-B8A1-4587-B0DC-39C5C807E6F6Q35225191-5AEDB50D-65B6-452E-B00F-7A7216913145Q35251105-008EAF53-3229-4EA2-9B34-DF924791F8C6Q35555679-D17E6E6F-09F1-4B9C-B790-FFA067F3D930Q35556999-33854931-5213-4A7E-ADF3-EFD7504752F3Q35608138-61D2BBCC-EE5C-4A2A-B336-F0914E3EAE7CQ35688177-D2694273-25EF-493C-AB54-D6CF9D5FB502Q35770332-357EBE35-B991-4B01-A927-0C3F32D622EFQ36210780-03127F10-E8C5-4CCF-81D8-0989A2E95F76Q36462821-0C7034E0-E2EB-4F6F-8B88-A91B756C25DB
P2860
Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Fascin, an actin-bundling prot ...... s and differentiation in vitro
@ast
Fascin, an actin-bundling prot ...... s and differentiation in vitro
@en
Fascin, an actin-bundling prot ...... s and differentiation in vitro
@nl
type
label
Fascin, an actin-bundling prot ...... s and differentiation in vitro
@ast
Fascin, an actin-bundling prot ...... s and differentiation in vitro
@en
Fascin, an actin-bundling prot ...... s and differentiation in vitro
@nl
prefLabel
Fascin, an actin-bundling prot ...... s and differentiation in vitro
@ast
Fascin, an actin-bundling prot ...... s and differentiation in vitro
@en
Fascin, an actin-bundling prot ...... s and differentiation in vitro
@nl
P2093
P2860
P3181
P1476
Fascin, an actin-bundling prot ...... s and differentiation in vitro
@en
P2093
Aida U Jawhari
Andrea Buda
Catherine Sarraf
Josephine C Adams
Khurram Shehzad
Masao Noda
Massimo Pignatelli
Michael J G Farthing
Michelle Jenkins
P2860
P3181
P356
10.1016/S0002-9440(10)63799-6
P407
P577
2003-01-01T00:00:00Z